(Q43299397)

18 November 2017

Analytical characterization of the APTIMA HPV Assay (English)

1 reference

18 November 2017

Janel Dockter

1

1 reference

18 November 2017

Astrid Schroder

2

1 reference

18 November 2017

Barbara Eaton

3

1 reference

18 November 2017

Ann Wang

4

1 reference

18 November 2017

Nathan Sikhamsay

5

1 reference

18 November 2017

Liezel Morales

6

1 reference

18 November 2017

Cristina Giachetti

7

1 reference

18 November 2017

1 July 2009

1 reference

Journal of Clinical Virology

18 November 2017

1 reference

18 November 2017

45 Suppl 1

1 reference

18 November 2017

S39-47

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

18 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Classification of papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Molecular diagnostic testing for infectious diseases using TMA technology

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Simultaneous detection of multiple nucleic acid targets in a homogeneous format

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Single-copy gene detection using branched DNA (bDNA) in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Detection and characterization of human papillomavirus type 45 DNA in the cervical carcinoma cell line MS751.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970007-1

7 January 2021

10.1016/S1386-6532(09)70007-1

Identifiers

DOI

1 reference

18 November 2017

1 reference